Healthcare provider profile · identity verified

Bruce D Campbell, MD

Family Practice · FREE UNION, VA · NPI 1700922457

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	360	109
Pantoprazole Sodium	Pantoprazole Sodium	245	72
Cephalexin	Cephalexin	199	122
Meloxicam	Meloxicam	187	60
Metoprolol Succinate	Metoprolol Succinate	178	52
Levothyroxine Sodium	Levothyroxine Sodium	167	41
Losartan Potassium	Losartan Potassium	162	49
Amlodipine Besylate	Amlodipine Besylate	151	47
Lisinopril	Lisinopril	133	43
Simvastatin	Simvastatin	124	36
Metformin Hcl	Metformin Hcl	117	34
Escitalopram Oxalate	Escitalopram Oxalate	115	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	114	30
Celecoxib	Celecoxib	108	33
Trazodone Hcl	Trazodone Hcl	103	29
Cefuroxime	Cefuroxime Axetil	96	67
Clonazepam	Clonazepam	90	28
Metoprolol Tartrate	Metoprolol Tartrate	89	24
Prednisone	Prednisone	88	69
Tamsulosin Hcl	Tamsulosin Hcl	88	24
Azithromycin	Azithromycin	84	72
Eliquis	Apixaban	80	17
Olmesartan Medoxomil	Olmesartan Medoxomil	80	20
Zolpidem Tartrate	Zolpidem Tartrate	78	28
Pravastatin Sodium	Pravastatin Sodium	75	23
Clarithromycin	Clarithromycin	73	41
Tramadol Hcl	Tramadol Hcl	73	36
Diclofenac Sodium	Diclofenac Sodium	71	18
Atenolol	Atenolol	69	21
Sertraline Hcl	Sertraline Hcl	69	17
Gabapentin	Gabapentin	68	21
Rosuvastatin Calcium	Rosuvastatin Calcium	66	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	64	39
Furosemide	Furosemide	63	24
Methylprednisolone	Methylprednisolone	61	49
Doxycycline Hyclate	Doxycycline Hyclate	57	34
Albuterol Sulfate Hfa	Albuterol Sulfate	56	21
Allopurinol	Allopurinol	55	15
Citalopram Hbr	Citalopram Hydrobromide	55	16
Valacyclovir	Valacyclovir Hcl	55	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	14
Spironolactone	Spironolactone	52	suppressed
Montelukast Sodium	Montelukast Sodium	50	13
Finasteride	Finasteride	49	16
Fluconazole	Fluconazole	48	18
Telmisartan	Telmisartan	48	15
Testosterone Cypionate	Testosterone Cypionate	45	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	25
Estradiol	Estradiol	41	12
Lorazepam	Lorazepam	41	14
Glipizide Er	Glipizide	39	16
Metformin Hcl Er	Metformin Hcl	39	suppressed
Omeprazole	Omeprazole	39	11
Xarelto	Rivaroxaban	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	11
Hydrochlorothiazide	Hydrochlorothiazide	36	12
Bupropion Hcl	Bupropion Hcl	35	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Buspirone Hcl	Buspirone Hcl	33	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Clobetasol Propionate	Clobetasol Propionate	27	11
Clonidine Hcl	Clonidine Hcl	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Famotidine	Famotidine	25	suppressed
Nabumetone	Nabumetone	24	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	23	suppressed
Mupirocin	Mupirocin	23	13
Myrbetriq	Mirabegron	23	suppressed
Progesterone	Progesterone, Micronized	23	suppressed
Ketoconazole	Ketoconazole	22	12
Warfarin Sodium	Warfarin Sodium	22	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	11
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	12
Glipizide	Glipizide	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Valsartan	Valsartan	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Digoxin	Digoxin	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Ozempic	Semaglutide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Constulose	Lactulose	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error